03.05.2018 • NewsChandra AsriElaine Burridge

Chandra Asri Awards Petchem Complex Contracts

Chandra Asri Awards Petchem Complex Contracts (c) George Clerk/Getty Images
Chandra Asri Awards Petchem Complex Contracts (c) George Clerk/Getty Images

Indonesia’s largest integrated petrochemical company, Chandra Asri Petrochemical (CAP), has awarded six technology license and engineering contracts for its proposed second petrochemical complex. CAP said the awards are a significant milestone in its plan to expand its petrochemical footprint.

The company has selected technology from the following companies: CB&I for the naphtha cracker and butadiene plants; GTC Technology for aromatics (benzene, toluene and xylenes); Texplore for HDPE; and LyondellBasell for LDPE and PP.

The multi-billion dollar facility will be located adjacent to an existing complex in Cilegon and will comprise a 1.1 million t/y ethylene cracker and plants producing 600,000 t/y of propylene, 175,000 t/y butadiene, 363,000 t/y benzene, 450,000 t/y HDPE, 300,000 t/y LDPE and 450,000 t/y PP.

In April 2017, CAP set up a wholly owned subsidiary, Chandra Asri Perkasa (CAP2), to undertake a feasibility study on the complex, which is anticipated to cost around $4-5 billion.

CAP said that once the second complex is fully operational, it will be better able to meet Indonesia’s demand for petrochemicals, which is heavily reliant on imports. A timescale for the project has not been revealed.

 

 

 

Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

Interview

Stability in Motion
Strategic Response to a Shifting Pharma Landscape

Stability in Motion

Stefan Oelrich, Member of the Board of Management and President Pharmaceuticals, Bayer, discusses navigating external volatility, reshaping its internal structures, and investing in future-ready capabilities to ensure sustainable growth.

most read

Photo
28.07.2025 • NewsChemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.